Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Financing Cash Flow history
Currency unavailable · from the cash flow
No Financing Cash Flow data reported for this period type.
Financing Cash Flow vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.24B USD | +1293.8% | +0.5% | 1750.0% | |
| LTM Mar 2026 | $111.36M USD | +8.0% | — | — | |
| LTM Mar 2026 | $57.73M USD | +12.7% | +11.7% | 25658.2% | |
| FY2025 | $42.57M USD | — | — | 228.7% | |
| LTM Jun 2026 | $41.68M USD | -91.1% | -57.8% | 585.3% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | +10.3% | +0.5% | 1167.7% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.